๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Clinical Study of Cizutamig in Systemic Lupus Erythematosus
NCT07215663Systemic Lupus Erythematosus (SLE)
Candid Therapeutics
Phase 1
47
Beijing, Guangzhou, Luoyang, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai
2025-09-04
Recruiting
A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
NCT06732323Triple-Negative Breast Cancer (TNBC)
Qilu Pharmaceutical Co., Ltd.
Phase 3
504
Beijing
2025-09-04
Recruiting
A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
NCT07137910Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 2
200
Beijing, Jilin City, Chongqing, Xiamen, Guangzhou, Shenzhen, Nanning, Zhengzhou
2025-09-04
Recruiting
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NCT07139301Ischemic Stroke, Atrial Fibrillation
Capital Medical University
Not applicable
438
Maโ€™anshan, Beijing, Zhangzhou, Heyuan, Qinzhou, Baoding, Harbin, Jiamusi
2025-09-04
Recruiting
DIND in Patients With aSAH : Real World Study
NCT07160088Aneurysmal Subarachnoid Hemorrhage (aSAH)
Xuanwu Hospital, Beijing
Observational
10,000
Beijing
2025-09-03
Recruiting
A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects
NCT07099118Non - Alcoholic Steatohepatitis
Sunshine Lake Pharma Co., Ltd.
Phase 1
96
Beijing
2025-09-03
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Beijing, Changchun, Changde, Changsha, Changzhou, Chengdu, Chongqing, Daqing
2025-09-02
Active, closed
A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNฮฑ for the Treatment of Hepatitis B
NCT07135349Chronic Hepatitis B
Shanghai Argo Biopharmaceutical Co., Ltd.
Phase 2
209
Hefei, Beijing, Sichuan, Chongqing, Fuzhou, Guangzhou, Shenzhen, Zunyi
2025-09-02
Recruiting
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
NCT07093814Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.
Phase 1/2
42
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Zhuhai, Nanning, Jinan
2025-09-02
Active, closed
A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligodendroglioma (VICTORIA Study)
NCT06969352Gliomas
Servier (Tianjin) Pharmaceutical Co. LTD.
Not applicable
62
Beijing, Qionghai, Chengdu
2025-09-02
Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT07164443Metastatic Castration-resistant Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 3
1,203
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Nanjing, Nanning, Nantong
2025-09-02
Recruiting
Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina
NCT07392281Non-Coronary Obstructive Angina
China-Japan Friendship Hospital
Phase EARLY_PHASE1
40
Beijing
2025-09-01
Active, closed
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
NCT07060885Allergic Rhinoconjunctivitis, Allergic Rhinitis
ALK-Abellรณ A/S
Phase 3
327
Beijing, Fuzhou, Guangzhou, Shenzhen, Zhuhai, Nanning, Haikou, Changshacun
2025-09-01
Not yet open
A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone๏ผˆT-CHP๏ผ‰ in Previously Untreated Patients With CD20-positive DLBCL
NCT07035379Diffuse Large B-Cell Lymphoma (DLBCL)
Zhejiang Teruisi Pharmaceutical Inc.
Phase 1/2
66
Beijing
2025-09-01
Not yet open
Linperlisib in the Treatment of aPRCA
NCT07031115Acquired Pure Red Cell Aplasia
Peking Union Medical College Hospital
Phase 2
15
Beijing
2025-09-01
By invitation
TACE Treats Nodular Goiter
NCT07258199Nodular Goiter
Peking Union Medical College Hospital
Not applicable
30
Beijing
2025-09-01
Not yet open
Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules
NCT07135297Lung Cancer (Diagnosis)
Shanghai Chest Hospital
Not applicable
465
Beijing, Zhengzhou, Nanjing, Ningbo, Shanghai
2025-09-01
Not yet open
Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial
NCT07133932Cerebral Infarction, Mechanical Ventilation, Acute Cerebrovascular Accident, Adult
Xuanwu Hospital, Beijing
Not applicable
590
Beijing, Shijiazhuang
2025-09-01
Recruiting
Validation of RCC Predicting Model With Emulated-target Trial
NCT07117227Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Tumor Thrombus, Prognosis
Peking University Third Hospital
Observational
4,700
Beijing
2025-09-01
Active, closed
Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing Interpretability
NCT07321288Psoriasis, Insulin Resistance
Chinese PLA General Hospital
Observational
1,265
Beijing
2025-09-01
Recruiting
Lung Recruitment Assessed by 2D/3D-EIT and R/I Ratio in Acute Respiratory Failure Patients With Mechanical Ventilation
NCT07379242Acute Respiratory Failure (ARF)
Peking Union Medical College Hospital
Observational
50
Beijing
2025-09-01
Recruiting
Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia
NCT07321301B-cell Lymphoma Refractory
Daihong Liu
Phase 2
10
Beijing
2025-09-01
Recruiting
Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer
NCT07156045Prostate Cancer Castration-resistant Prostate Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
10
Beijing
2025-09-01
Active, closed
Data Mining of Population Health-sub-health-disease Based on Dynamic System Theory
NCT07375303Sub-healthy
Beijing Friendship Hospital
Observational
380,000
Beijing
2025-09-01
Recruiting
UBT251 Injection Phase II Clinical Study (CKD)
NCT07134335Obesity &Amp; Overweight, Chronic Kidney Disease
The United Bio-Technology (Hengqin) Co., Ltd.
Phase 2
180
Beijing
2025-09-01
Not yet open
A Study on Cardiopulmonary Exercise Tolerance Standards for Healthy Chinese Population
NCT07108296Oxygen Consumption, Cardiorespiratory Fitness
Affiliated Hospital of Changchun University of Chinese Medicine
Observational
4,620
Beijing, Quanzhou, Guangzhou, Nanning, Daqing, Harbin, Puyang, Zhengzhou
2025-09-01
Not yet open
Research on Ultrasound Diagnostic Criteria for Intracranial and Extracranial Arterial Serial Stenosis
NCT06947720Ischemic Stroke, Carotid Stenosis
Xuanwu Hospital, Beijing
Observational
700
Beijing
2025-09-01
Recruiting
Artificial Intelligence Used in Screening Adrenal Nodules
NCT07198152Adrenal Incidentalomas, Thoracic CT-scan
Peking University First Hospital
Observational
600
Beijing
2025-09-01
Not yet open
A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome
NCT07145060Primary Sjรถgren's Syndrome (pSS)
China-Japan Friendship Hospital
Not applicable
105
Beijing
2025-09-01
Recruiting
Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia
NCT07512700Acute Monocytic Leukemia
Chinese PLA General Hospital
Phase 2
204
Beijing
2025-09-01
Active, closed
Artificial Intelligence Assisting Transcatheter Mitral Edge-to-Edge Repair
NCT07632794Mitral Regurgitation
Mi Chen
Observational
1,500
Beijing
2025-09-01
Recruiting
Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma
NCT07725783Ewing Sarcoma
Peking University People's Hospital
Observational
100
Beijing
2025-09-01
Recruiting
Hemodynamic Effects of Norepinephrine Reduction on Critical Closing Pressure in Distributive Shock
NCT07653659Distributive Shock, Hemodynamic Assessment, Critical Illness
Peking Union Medical College Hospital
Observational
30
Beijing
2025-09-01
Recruiting
The Effect of Perioperative Transcutaneous Electrical Acupoint Stimulation Combined With Traditional Chinese Medicine on Gastrointestinal Function Recovery in Patients Undergoing Abdominal Surgery
NCT07081802ERAS, Traditional Chinese Medication (TCM)
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
148
Beijing
2025-09-01
Not yet open
Effect of Target Temperature Management on Intestinal Flora and Its Metabolites in Patients With Cardiac Arrest
NCT06974682Cardiac Arrest (CA)
Capital Medical University
Observational
35
Beijing
2025-09-01
Recruiting
Study on the Clinical Efficacy of Transcranial Strong Alternating Current (Hi-tACS) in Patients With Neuroimmune Diseases With Insomnia
NCT07558616Neuroimmune Diseases With Insomnia
Xuanwu Hospital, Beijing
Not applicable
80
Beijing
2025-09-01
Recruiting
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
NCT07068438Chronic Bronchitis, COPD (Chronic Obstructive Pulmonary Disease)
Suzhou Hengruihongyuan Medical Technology Co. LTD
Not applicable
210
Hefei, Beijing, Changzhou, Suzhou, Wuxi, Xuzhou, Nanchang, Hangzhou
2025-09-01
Recruiting
AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study
NCT07312318Coronary Heart Disease (CHD)
China-Japan Friendship Hospital
Observational
12,000
Beijing
2025-09-01
Recruiting
Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
NCT07694648Respiratory Tract Infections (RTI), Respiratory Syndrome, Acute, Severe, Acute Respiratory Infections (ARIs)
Huashan Hospital
Observational
2,398
Beijing, Guangzhou, Zhuhai, Shijiazhuang, Harbin, Jiamusi, Shangqiu, Zhengzhou
2025-09-01
Not yet open
Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
NCT07116811Vestibular Schwannoma, Facial Nerve Paralysis
Beijing Tiantan Hospital
Phase 3
364
Beijing
2025-09-01
Not yet open
Study of CM313 in Subject With IgA Nephropathy
NCT06830395IgA Nephropathy
Keymed Biosciences Co.Ltd
Phase 2
106
Beijing
2025-09
Not yet open
Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies
NCT07110194CD20-positive Hematological Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1
75
Beijing
2025-09
Not yet open
Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
NCT07088731Cervical Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
180
Beijing
2025-09
Not yet open
Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
NCT05576766Prostate Cancer, Robot-Assisted Laparoscopic Radical Prostatectomy, Enhanced Recovery After Surgery (ERAS) Protocol, Prehabilitation
Peking University First Hospital
Not applicable
54
Beijing
2025-09
Not yet open
Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
NCT07142837Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
153
Beijing
2025-09
Not yet open
A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension
NCT07152444Uncontrolled Hypertension
Qilu Pharmaceutical Co., Ltd.
Phase 1
78
Beijing
2025-09
Not yet open
A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL.
NCT06886139CD20-positive Diffuse Large B-Cell Lymphoma
Zhejiang Teruisi Pharmaceutical Inc.
Phase 2
139
Beijing
2025-09
Not yet open
A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
NCT07106372Atopic Dermatitis
Keymed Biosciences Co.Ltd
Phase 3
240
Beijing
2025-09
Recruiting
INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)
NCT07089862Unruptured Intracranial Aneurysm, Indobufen
Beijing Tiantan Hospital
Not applicable
2,500
Beijing
2025-08-31
Not yet open
Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis
NCT07131150Idiopathic Pulmonary Fibrosis (IPF)
Ruijin Hospital
Phase 2
66
Beijing, Guangzhou, Shenzhen, Hebei, Zhengzhou, Wuhan, Changsha, Nanjing
2025-08-31
Not yet open
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
NCT07139548T2DM
Guangdong Raynovent Biotech Co., Ltd
Phase 3
600
Beijing
2025-08-31
Not yet open
Early Blood Pressure Intervention After Coiling or Clipping for Subarachnoid Hemorrhage
NCT07149922Aneurysmal Subarachnoid Hemorrhage, Aneurysmal Subarachnoid Hemorrhage (aSAH)
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-08-31
Recruiting
Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome
NCT07096102Metabolic Syndrome (MetS)
Meihua Ji
Not applicable
310
Beijing
2025-08-31
Not yet open
Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer
NCT07159217Biliary Tract Cancer, Disitamab Vedotin, Lenvatinib, Immune Checkpoint Inhibitors
Peking Union Medical College Hospital
Phase 2
65
Beijing
2025-08-30
Recruiting
Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways
NCT07129174Ventilator-Associated Pneumonia (VAP), Intensive Care Unit (ICU) Patients, Microbiome Dysbiosis
Jian-Xin Zhou
Observational
220
Beijing
2025-08-30
Recruiting
Development and Validation of Delirium Recognition Using Computer Vision in Neuro-critical Patients
NCT07136207Delirium, Artificial Intelligence (AI)
Beijing Tiantan Hospital
Observational
1,000
Beijing
2025-08-30
Not yet open
Impact of Delayed Cord Clamping and Minimally Invasive Surfactant Administration on Outcomes in Premature Infants Less Than 30 Weeks Gestation
NCT07092319NRDS
Peking University Third Hospital
Observational
518
Beijing
2025-08-30
Not yet open
A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients
NCT07111442Renal Artery Stenosis Atherosclerotic, Secondary Hypertension Renal Arterial
Peking University First Hospital
Not applicable
200
Beijing
2025-08-30
Recruiting
Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.
NCT07443397Whole-Brain Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
134
Beijing
2025-08-29
Recruiting
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
NCT07237568Ankylosing Spondylitis
Lynk Pharmaceuticals Co., Ltd
Phase 3
352
Beijing
2025-08-29
Recruiting
Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
NCT07066826Alzheimer Dementia
Wanbangde Pharmaceutical Group Co., LTD
Phase 2/3
720
Beijing
2025-08-29
Recruiting
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
NCT07165886Gastroenteropancreatic Neuroendocrine Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2/3
298
Beijing
2025-08-29
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Beijing, Harbin, Zhengzhou
2025-08-28
Recruiting
A Study of LM-350 in Subjects With Advanced Solid Tumours
NCT07112222Malignant Tumors
LaNova Medicines Limited
Phase 1/2
80
Beijing
2025-08-28
Recruiting
Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)
NCT07110090Thrombocytopenia, Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
16
Beijing
2025-08-28
Active, closed
Adverse Events Among Hospitalized Patients in China
NCT07705204Adverse Event
Peking Union Medical College Hospital
Observational
2,807
Beijing
2025-08-28
Recruiting
A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors
NCT07123129Advanced Malignancy
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
200
Beijing, Hangzhou
2025-08-28
Recruiting
Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
NCT07146100Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Observational
200
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Foshan, Guangzhou
2025-08-28
Recruiting
PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
NCT07106970Persistent Atrial Fibrillation
Boston Scientific Corporation
Not applicable
640
Beijing
2025-08-28
Recruiting
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
NCT07084012Acute Ischemic Stroke AIS
Shenzhen Wingor Biotechnology Co., Ltd.
Phase 2
60
Beijing
2025-08-27
Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07043400Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
BeOne Medicines
Phase 3
351
Hefei, Beijing, Xiamen, Anyang, Zhengzhou, Nanjing, Ganzhou, Shenyang
2025-08-27
Recruiting
A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors
NCT07147348Advanced Solid Tumor
BioNTech SE
Phase 1/2
375
Beijing, Hefei, Henan, Hunan, Shandong, Shanghai, Sichuan, Zhejiang
2025-08-27
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
NCT07145229Acute Gouty Arthritis, Gout Flare, Gout Flares, Acute Gout Flare
Atom Therapeutics Co., Ltd
Phase 2
380
Beijing, Nanning, Langfang, Wuhan, Xiangtan, Zhuzhou, Huai'an, Pingxiang
2025-08-26
Not yet open
To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery
NCT07121023Postoperative Analgesia After Unilateral Hallux Valgus Correction Surgery
Beijing Tide Pharmaceutical Co., Ltd
Phase 1
32
Beijing
2025-08-26
Recruiting
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma
NCT07754890Cutaneous T-cell Lymphoma (CTCL)
Peking Union Medical College Hospital
Phase 1/2
65
Beijing
2025-08-26
Not yet open
Child Vaccination Scheduling in China
NCT07141875Vaccination Behavior
Peking University
Observational
6,000
Beijing
2025-08-25
Recruiting
LineMatrixยฎ Biological Vascular Graft for the Creation of Arteriovenous Graft
NCT07773051Arteriovenous Graft
Longhua Hospital
Not applicable
326
Beijing, Chongqing, Shenzhen, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Nanchang
2025-08-25
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
NCT07096843Primary Membranous Nephropathy
Climb Bio, Inc.
Phase 2
45
Beijing, Shenzhen, Wuxi, Xi'an, Jinan, Yantai, Yibin
2025-08-25
Recruiting
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
NCT06923280Hepatitis B, Chronic
Huashan Hospital
Not applicable
72
Beijing, Shanghai
2025-08-25
Recruiting
CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
NCT07383246Medullary Thyroid Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
150
Beijing
2025-08-25
Recruiting
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
NCT07594964Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer), Pancreatic Ductal Adenocarcinoma (PDAC), Hepatocellular Carcinoma (HCC), Gastric Cancer (GC)
Shenzhen Xinhe Biomedical
Phase 1
48
Beijing
2025-08-25
Recruiting
Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus
NCT07010835Systemic Lupus Erythematosus (SLE)
Excyte Biopharma Ltd
Phase 1/2
189
Beijing
2025-08-25
Recruiting
Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster
NCT07099157Herpes Zoster
Peking University Third Hospital
Phase 4
140
Beijing
2025-08-25
Recruiting
A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
NCT07616700IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
73
Beijing
2025-08-25
Not yet open
Arrhythmia Cohort Study
NCT07123896Arrhythmia
Beijing Anzhen Hospital
Observational
10,000
Beijing
2025-08-24
Recruiting
A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC
NCT07334483HCC
GrandPharma (China) Co., Ltd.
Phase 2
120
Beijing, Nanjin, Shanghai
2025-08-22
Recruiting
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
NCT07201467End-Stage Renal Disease Requiring Haemodialysis
Suzhou Alphamab Co., Ltd.
Phase 1/2
12
Beijing
2025-08-22
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation
Not applicable
1,616
Beijing, Beijin, Guangzhou, Wuhan, Xi'an
2025-08-21
Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
NCT07058077Heterozygous Familial Hypercholesterolemia (HeFH)
Merck Sharp & Dohme LLC
Phase 2/3
153
Beijing, Guangzhou, Shanghai, Hangzhou
2025-08-21
Recruiting
A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
NCT07082686Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
75
Hefei, Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanning, Zhengzhou
2025-08-21
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
NCT07154706Non-small Cell Lung Cancer (NSCLC)
Nuvation Bio Inc.
Phase 3
180
Beijing, Guangzhou, Nanning, Zhengzhou, Wuhan, Nanjing, Nantong, Nanchang
2025-08-21
Recruiting
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
NCT07111832PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
400
Beijing, Shanghai
2025-08-20
Recruiting
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
NCT07230652Schizophrenia, Alzheimer's Disease Psychosis
Luye Pharma Group Ltd.
Phase 1
40
Beijing
2025-08-20
Not yet open
Clinical Observation and Risk Factor Analysis of the Incidence of Postoperative PTSD in Children
NCT07088692PTSD
JianHao Zhang
Observational
400
Beijing
2025-08-20
Recruiting
The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
NCT07065968Immune Thrombocytopenia (ITP)
Peking University People's Hospital
Phase 2
132
Beijing
2025-08-19
Recruiting
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT07133750CRC (Colorectal Cancer)
Biotheus Inc.
Phase 2
100
Beijing, Guangzhou, Harbin, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2025-08-19
Recruiting
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
NCT07059650Diffuse Large B-Cell Lymphoma
Dizal Pharmaceuticals
Phase 1/2
150
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Linyi, Taiyuan
2025-08-19
Recruiting
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
NCT07097818Type 1 Diabetes
Second Xiangya Hospital of Central South University
Not applicable
400
Beijing, Quanzhou, Shenzhen, Tangshan, Luoyang, Wuhan, Changsha, Shenyang
2025-08-18
Not yet open
XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer
NCT07114666Pancreatic Cancer
Peking Union Medical College Hospital
Not applicable
12
Beijing
2025-08-18
Recruiting
Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants
NCT07182656Rheumatoid Arthritis (RA)
Yi Fang
Phase 1
70
Beijing
2025-08-18
Rows per page Showing 1701–1800 of 5484
Previous 16 17 18 19 20 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=18

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.